Ozempic and Wegovy make the list of the next 15 drugs in Medicare negotiations: HHS
Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer treatment Calquence, GSK’s chronic obstructive pulmonary disorder (COPD) drug Breo Ellipta, and AbbVie’s antipsychotic medication Vraylar.
Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and ...
Xavier Becerra is reflecting on tenure as HHS secretary. He told Scripps News, "We're leaving this country is healthier and ...
Paul Mango, a senior health official during President-elect Donald Trump's first term who was a member of Trump's current ...
Last June, the Supreme Court issued its decision in Securities and Exchange Commission v. Jarkesy, which holds that the ...
As of Monday, FDA commissioner Robert Califf, Department of Health and Human Services (HHS) Secretary Xavier Becerra, ...
HHS told the Second Circuit that Boehringer Ingelheim’s voluntary participation in Medicare negotiations “undermines” its ...
Lewiston, Maine-based St. Mary's Health System is suing HHS for allegedly unlawfully withholding Medicare payments from the cash-strapped system, Maine Public Radio reported Jan. 14.
Hosted on MSN5d
After Mandating Vaccines And Censoring Conservatives, Biden’s HHS Sec Wonders Why Nobody Trusts His AgencyXavier Becerra, President Joe Biden’s outgoing Health and Human Services (HHS) secretary, is lamenting Americans’ abysmal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback